Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is not intended to diagnose, treat, cure, or prevent any disease or condition
Last reviewed: June 3, 2026 Last updated: June 3, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The placebo group recorded only a 4.5% reduction in total fat mass, while retatrutide recipients saw fat mass fall by 15.2% in the 4mg group, 26.1% in the 8mg group and 23.2% in the 12mg group
In some cases, no GLP-1 will be tolerable
It includes access to Noom's digital longevity companion for behavioral support, at-home health testing to monitor 17 biomarkers for long-term health and personalized GLP-1 microdosing for those who qualify
D.AmarJ.IglesiasM
US$ 29.45
US$ 22.52
US$ 21.94
